D97 | 'Our culture kills us.' Effective community based communication of HIV pre-exposure prophylaxis (PrEP) in Eswatini | E-poster | Pre-exposure prophylaxis |
D97 | "I had condomless sex, but I'm calm because I use PrEP": Experiences of adolescent's men who have sex with men and transgender women with daily oral PrEP in Brazil | E-poster | Pre-exposure prophylaxis |
D97 | Depressive symptoms and heavy alcohol use predict transmission risk behaviors among new oral PrEP clients in Kenya: results from a prospective cohort study | E-poster | Pre-exposure prophylaxis |
D97 | Condomless sex and partner safe sex conflict: a latent class analysis among at-risk Black and Latinx sexual and gender minority youth (BLSGMY) assigned male sex at birth | E-poster | Pre-exposure prophylaxis |
D97 | 'Reaching adolescents where they are': Innovative recruitment strategies for PrEP enrolment of adolescent´s key population in Brazil | E-poster | Pre-exposure prophylaxis |
B53 | Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV'an exploratory objective of the IMPAACT P1078 randomized trial | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B53 | Adverse perinatal outcomes associated with timing of initiation of antiretroviral therapy: systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B53 | Comparable pregnancy outcomes for HIV-uninfected and HIV-infected women on antiretroviral treatment in Kenya | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B53 | A comparative multi-country analysis of the impact of COVID-19 on HIV services for pregnant and breastfeeding women and their infants | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
C27 | Global adoption of guidelines on and use of oral pre-exposure prophylaxis (PrEP): current situation and future projections | On-demand oral abstract session | PrEP |